Idioma:

Multidimensional biomarker approach integrating tumor markers, inflammatory indicators, and disease activity indicators may improve prediction of rheumatoid arthritis-associated interstitial lung disease

Wan, Jin ; Yu, Zhibo ; Cao, Xiaoyu ; Zhao, Xuejian ; Zhou, Wei ; Zheng, Yi

Clinical rheumatology, 2024-06, Vol.43 (6), p.1855-1863 [Revista revisada por pares]

Cham: Springer International Publishing

Texto completo disponible

Citas Citado por

Acciones

Título:
Multidimensional biomarker approach integrating tumor markers, inflammatory indicators, and disease activity indicators may improve prediction of rheumatoid arthritis-associated interstitial lung disease
Autor: Wan, Jin ; Yu, Zhibo ; Cao, Xiaoyu ; Zhao, Xuejian ; Zhou, Wei ; Zheng, Yi
Materias: Accuracy ; Adult ; Aged ; Antigens ; Antigens, Neoplasm ; Arthritis, Rheumatoid - blood ; Arthritis, Rheumatoid - complications ; Arthritis, Rheumatoid - diagnosis ; Biomarkers ; Biomarkers - blood ; Biomarkers, Tumor - blood ; C-reactive protein ; C-Reactive Protein - analysis ; CA-19-9 Antigen - blood ; Citrulline ; Clinical outcomes ; Correlation analysis ; Cytokeratin ; Female ; Humans ; Keratin-19 - blood ; Leukocytes (neutrophilic) ; Logistic Models ; Lung diseases ; Lung Diseases, Interstitial - blood ; Lung Diseases, Interstitial - complications ; Lung Diseases, Interstitial - diagnosis ; Lung Diseases, Interstitial - etiology ; Lymphocytes ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Neutrophils ; Original Article ; Patients ; Regression analysis ; Rheumatoid arthritis ; Rheumatoid factor ; Rheumatology ; ROC Curve ; Severity of Illness Index ; Sialyl Lewis a antigen ; Tumor markers ; Tumors
Es parte de: Clinical rheumatology, 2024-06, Vol.43 (6), p.1855-1863
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descripción: Introduction Rheumatoid arthritis (RA) often leads to interstitial lung disease (ILD), significantly affecting patient outcomes. This study explored the diagnostic accuracy of a multi-biomarker approach to offer a more efficient and accessible diagnostic strategy for RA-associated ILD (RA-ILD). Methods Patients diagnosed with RA, with or without ILD, at Beijing Tiantan Hospital from October 2019 to October 2023 were analyzed. A total of 125 RA patients were included, with 76 diagnosed with RA-ILD. The study focused on three categories of indicators: tumor markers, inflammatory indicators, and disease activity measures. The heatmap correlation analysis was employed to analyze the correlation among these indicators. Logistic regression was used to determine odds ratios (OR) for indicators linked to RA-ILD risk. Receiver-operating characteristic (ROC) curve analysis was employed to evaluate the diagnostic potential of these indicators for RA-ILD. Results The results of logistic regression analysis showed that tumor markers (carbohydrate antigen 19–9 (CA19-9), carbohydrate antigen 125 (CA125), and cytokeratin 19 fragment (CYFRA21-1)), as well as inflammatory indicators (neutrophil, neutrophil-to-lymphocyte ratio (NLR), platelet, C-reactive protein (CRP)) and disease activity measures (disease activity score-28-CRP (DAS28-CRP), rheumatoid factor (RF), and anti-cyclic peptide containing citrulline (anti-CCP)), were significantly associated with RA-ILD. The correlation coefficients among these indicators were relatively low. Notably, the combination indicator 4, which integrated the aforementioned three categories of biomarkers, demonstrated improved diagnostic accuracy with an AUC of 0.857. Conclusion The study demonstrated that combining tumor markers, inflammatory indicators, and disease activity measures significantly enhanced the prediction of RA-ILD. Key Points • Multidimensional strategy: Integrated tumor markers, inflammatory indicators, and disease activity measures to enhance early detection of rheumatoid arthritis-associated interstitial lung disease (RA-ILD) . • Diagnostic accuracy: Employed heatmap correlation and logistic regression, identifying significant associations and improving diagnostic accuracy with a multidimensional biomarker combination . • Superior performance: The combined multidimensional biomarker strategy demonstrated higher diagnostic precision compared to individual or dual-category indicators . • Clinical relevance: Offers a promising, accessible approach for early detection of RA-ILD in clinical settings, potentially improving patient outcomes .
Editor: Cham: Springer International Publishing
Idioma: Inglés

Enlaces

View this record in MEDLINE/PubMed

Volver a la lista de resultados

Resultado 1 Siguiente Ir a la siguiente página

Realización: Logos de Redes Sociales:

Multidimensional biomarker approach integrating tumor markers, inflammatory indicators, and disease activity indicators may improve prediction of rheumatoid arthritis-associated interstitial lung disease

Wan, Jin ; Yu, Zhibo ; Cao, Xiaoyu ; Zhao, Xuejian ; Zhou, Wei ; Zheng, Yi

Cham: Springer International Publishing

Buscando en bases de datos remotas, por favor espere